SynthesisFrontiers in immunology2026
Global trends and hotspots of macrophage-related research in intervertebral disc degeneration from 2005 to 2025: a bibliometric and visualized analysis.
Synthesis in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Macrophage-mediated imbalances in the immune microenvironment are critical to the pathogenesis of intervertebral disc degeneration (IVDD). Consequently, targeting macrophage polarization to remodel the degenerative microenvironment and promote tissue repair has emerged as a major research hotspot. However, systematic bibliometric analyses of this interdisciplinary field remain scarce. This study utilizes bibliometric methods to elucidate the current landscape, intellectual base, and research frontiers of macrophage involvement in IVDD, providing quantitative data to support the development of novel immunotherapies. Methods: We retrieved literature investigating the role of macrophages in IVDD, published between 2005 and 2025, from the WoSCC and Scopus databases. Following deduplication and data standardization, 550 publications were included. We employed CiteSpace, VOSviewer, and the R package "bibliometrix" to conduct visual analyses of contributing countries, institutions, journals, and authors. Additionally, we mapped keyword co-occurrence and citation burst networks to quantitatively evaluate evolutionary trends and research hotspots. Results: Publications in this field have surged significantly since 2021. China and USA are the primary contributors, although multinational collaborative networks remain limited. Conclusion: IVDD research has undergone a critical paradigm shift, transitioning from traditional morphological observation to precision immunometabolic intervention. Currently, the research frontier focuses on integrating high resolution single cell transcriptomics with advanced nanoscale delivery systems, such as lipid nanoparticles and functionalized hydrogels, to proactively reprogram macrophage phenotypes. Ultimately, this study provides a robust quantitative framework to guide the clinical development of targeted nonsurgical immunotherapies and regenerative strategies for discogenic pain.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.